Surgery Doctors in Glenwood Springs, CO Accepting Medicare

5 Surgery doctors found. Showing 1 - 5

Misty Cumings, RNFA Surgery Medicare: Not Enrolled in Medicare Practice Location: 1906 Blake Ave, Glenwood Springs, CO 81601 Phone: 970-384-7180

Dr. Randall E Ross, MD Surgery Medicare: Accepting Medicare Assignments Practice Location: 1830 Blake Ave, Roaring Fork Surgical Assoc, Glenwood Springs, CO 81601 Phone: 970-945-6533    Fax: 970-945-3945

Mrs. Brady Katherine Heuer, RN, BSN, CNOR, RNFA Surgery Medicare: Not Enrolled in Medicare Practice Location: 1906 Blake Ave, Glenwood Springs, CO 81601 Phone: 970-384-7180

Dr. Mohammad Asem Bakkar, M.D. Surgery Medicare: Accepting Medicare Assignments Practice Location: 1906 Blake Ave, Glenwood Springs, CO 81601 Phone: 206-930-5885

Dr. Brad Nichol, MD Surgery Medicare: Accepting Medicare Assignments Practice Location: 1830 Blake Ave, #202 Roaring Fork Surgical, Glenwood Springs, CO 81601 Phone: 970-945-6533    Fax: 970-945-3945

News Archive

Report highlights recommendations to advance safety of childbirth in Indonesia

Indonesia is a fast-rising economic power that has made significant progress toward key development goals including reducing child mortality. But for reasons outlined in a National Academy of Sciences report by U.S. and Indonesian experts, the nation's estimated rates of maternal and neonatal mortality remain tragically high.

Stereotaxis extends strategic partnership to distribute magnetic ablation catheters

Stereotaxis, Inc. announced today that the Company and its existing strategic catheter partner have extended their exclusive worldwide agreement for the distribution of existing approved magnetic ablation catheters through the end of 2015.

ZEVALIN treatment for Non-Hodgkin lymphoma becomes simpler with removal of bioscan requirement

Spectrum Pharmaceuticals, a biotechnology company with fully integrated commercial and drug development operations with a primary focus in hematology and oncology, received approval from the U.S. Food and Drug Administration (FDA) on November 18, 2011 to remove the pre-treatment biodistribution evaluation requirement using Indium-111 ZEVALIN imaging dose followed by a gamma scan before administering the ZEVALIN therapeutic dose.

Abnormal attachment of sugar to BACE1 enzyme leads to formation of Aβ plaques in the brain

Researchers at the RIKEN-Max Planck Joint Research Center in Japan have demonstrated that hallmark symptoms of Alzheimer's disease can be reduced when sugars are prevented from binding to one of the key enzymes implicated in the disease. The new findings, reported in EMBO Molecular Medicine, show that abnormal attachment of a particular sugar to the enzyme BACE1 is a critical factor leading to the formation of Aβ plaques in the brain, and that plaques were reduced and cognitive performance improved when this action was prevented in mice through loss of the enzyme GnT-III.

Read more Medical News

› Verified 4 days ago